Patents by Inventor Charles Mark Ensor

Charles Mark Ensor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEG-modified uricase
    Patent number: 6913915
    Abstract: The present invention is directed to uricase modified with polyethylene glycol and to methods of treating different illnesses characterized by increased circulating uric acid levels, including but not limited to, hyperuricemia and tumor lysis syndrome.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: July 5, 2005
    Assignee: Phoenix Pharmacologics, Inc.
    Inventors: Charles Mark Ensor, Mike A. Clark, Frederick Wayne Holtsberg
  • Novel mutated form of arginine deiminase
    Publication number: 20040258675
    Abstract: The present invention discloses arginine deiminase that is genetically modified for more efficient manufacturing and processing. The present invention discloses recombinant DNA molecules and vectors and other therapeutic and pharmaceutical compositions. The present invention also discloses methods for preparing modified arginine deiminase as well as methods of treating cancer and other disease states using modified arginine deiminase.
    Type: Application
    Filed: August 21, 2003
    Publication date: December 23, 2004
    Applicant: Phoenix Pharmacologics, Inc.
    Inventors: Charles Mark Ensor, Frederick Wayne Holtsberg, Mike A. Clark
  • Mutated form of arginine deiminase
    Patent number: 6635462
    Abstract: The present invention discloses arginine deiminase that is genetically modified for more efficient manufacturing and processing. The present invention discloses recombinant DNA molecules and vectors and other therapeutic and pharmaceutical compositions. The present invention also discloses methods for preparing modified arginine deiminase as well as methods of treating cancer and other disease states using modified arginine deiminase.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: October 21, 2003
    Assignee: Phoenix Pharmacologies, Inc.
    Inventors: Charles Mark Ensor, Frederick Wayne Holtsberg, Mike A. Clark
  • PEG-modified uricase
    Publication number: 20030082786
    Abstract: The present invention is directed to uricase modified with polyethylene glycol and to methods of treating different illnesses characterized by increased circulating uric acid levels, including but not limited to, hyperuricemia and tumor lysis syndrome.
    Type: Application
    Filed: August 2, 2001
    Publication date: May 1, 2003
    Inventors: Charles Mark Ensor, Mike A. Clark, Frederick Wayne Holtsberg